Aurobindo Pharma Ltd.
SET SMS ALERT
| 5-Day | 86,390 |
| 10-Day | 137,187 |
| 30-Day | 223,491 |
| 5-Day | 86,390 |
| 10-Day | 137,187 |
| 30-Day | 223,491 |
Depth
Market Depth (20 Feb 2019)
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 50 | 722.00 | 722.20 | 28 |
| 5 | 720.55 | 723.35 | 1 |
| 500 | 720.50 | 723.45 | 50 |
| 1 | 719.00 | 723.90 | 500 |
| 1000 | 718.70 | 724.00 | 57 |
| 2147 | Total | 2622 | Total |
Buy Qty
2147
Sell QTY
2622
| 5-Day | 2,031,181 |
| 10-Day | 2,591,982 |
| 30-Day | 2,209,248 |
| 5-Day | 2,031,181 |
| 10-Day | 2,591,982 |
| 30-Day | 2,209,248 |
- Quote
- CHARTS
- NEWS
- COMMENTS13 new
- ANNOUNCEMENTS
- CORPORATE ACTION
- FINANCIALS
- ANNUAL REPORT
- SHAREHOLDING
- PEERS
- COMPANY INFO
- ALERTS
- Widgets
- BROKER
RESEARCH
Aurobindo Pharm
Sentimeter
100% of moneycontrol users recommend buying Aurobindo Pharm.
What's your call on Aurobindo Pharm today?
Read 13 investor views
Top Trading Ideas
15 February 2019
sell TitanCompany Feb Fut |
Entry Price (Rs) 1,043.55 |
Exit Price (Rs) 1,028.00 |
Gain (Rs) 16.00 |
sell UnitedBrewerie Feb Fut |
Entry Price (Rs) 1,401.45 |
Exit Price (Rs) 1,346.00 |
Gain (Rs) 55.00 |
| Days | BSE | NSE |
| 30 | 765.91 | 766.12 |
| 50 | 751.18 | 751.40 |
| 150 | 728.78 | 729.15 |
| 200 | 695.38 | 695.69 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Aurobindo Pharm
| Standalone | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
| Net Sales | 3,160.50 | 3,090.38 | 2,491.62 | 2,296.32 |
| Other Income | 136.87 | 4.18 | 2.82 | 6.36 |
| PBDIT | 598.32 | 606.97 | 396.76 | 477.88 |
| Net Profit | 463.51 | 380.95 | 225.12 | 308.29 |
(In Rs Cr)
| Total Share Capital | 58.59 |
| Net Worth | 9,982.58 |
| Total Debt | 3,653.83 |
| Net Block | 3,392.97 |
| Investments | 1,967.50 |
| Total Assets | 13,636.41 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 422.20 | 1.89 | 678.80 | 375.40 | 101,299.92 |
| Cipla | 541.05 | 0.34 | 678.00 | 483.75 | 43,592.10 |
| Aurobindo Pharm | 722.50 | 1.91 | 830.00 | 527.05 | 42,331.82 |
| Dr Reddys Labs | 2523.70 | -0.47 | 2875.00 | 1888.00 | 41,908.78 |
| Divis Labs | 1561.75 | -1.68 | 1697.65 | 981.05 | 41,459.56 |
| More » | |||||
| Dec' 18 | Dec' 18 | Dec' 18 | Sep' 18 | |
| Promoter | 51.87 | 51.87 | 51.87 | 51.87 |
| Public (FII + DII) | 48.13 | 48.13 | 48.13 | 48.13 |
| Others | 0.00 | 0.00 | 0.00 | 0.00 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| HDFC Balanced Advantage Fund (G) | 7,669,406 |
| HDFC Hybrid Equity Fund (G) | 5,558,952 |
| HDFC Equity Fund (G) | 3,632,408 |
| HDFC Top 100 Fund (G) | 2,993,655 |
Radico Khaitan Recommended on Sep 28th 2017
Recommended price 154.00 | Peak from reco 500.00 225.63%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
About Aurobindo Pharm
Aurobindo Pharm is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 42,314.25 crore.
The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P Sarath Chandra Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, M Sitarama Murthy - Non Exe. & Ind. Director, Avnit Bimal Singh - Non Exe. & Ind. Director, Savita Mahajan - Non Exe. & Ind. Director.
It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA.
Its Registered office is at Plot No.2, Maitri Vihar, Ameerpet,, Hyderabad,Telangana - 500038.
Their Registrars are Karvy Computershare Private Ltd.
